Transcatheter mitral valve repair with Mitraclip®: A nationwide experience

Shabib Abdulah Al-Asmi; Rasha Kaddoura; Mohammed Salah Abdelghani; Ashraf Ahmed; Cheik Abdoul Maaly; Hakam Alzaeem; Nazar Mohammed; Mohanad Shehadeh; Fahad Abdullah Al-Kindi; Awad Al-Qahtani; Mohammed Al-Hijji

doi:10.4103/heartviews.heartviews_90_23

		Login \| Users Online: 1675
Home \| About us \| Editorial board \| Search \| Ahead of print \| Current Issue \| Archives \| Submit article \| Instructions \| Subscribe \| Advertise \| Contact us

ORIGINAL ARTICLE

Year : 2023 | Volume : 24 | Issue : 4 | Page : 179-187

Transcatheter mitral valve repair with Mitraclip^®: A nationwide experience

Shabib Abdulah Al-Asmi¹, Rasha Kaddoura², Mohammed Salah Abdelghani¹, Ashraf Ahmed³, Cheik Abdoul Maaly⁴, Hakam Alzaeem⁴, Nazar Mohammed⁵, Mohanad Shehadeh¹, Fahad Abdullah Al-Kindi⁵, Awad Al-Qahtani⁵, Mohammed Al-Hijji⁵
¹ Department of Adult Cardiology, Heart Hospital, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
² Department of Pharmacy, Heart Hospital, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
³ Department of Internal Medicine, Heart Hospital, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
⁴ Department of Non-Invasive Cardiology, Heart Hospital, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
⁵ Department of Interventional Cardiology, Heart Hospital, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar

Correspondence Address:
Dr. Mohammed Al-Hijji
Department of Interventional Cardiology, Heart Hospital, Hamad Medical Corporation, P. O. Box 3050, Doha
Qatar

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/heartviews.heartviews_90_23

Background: Transcatheter mitral valve repair (TMVr), using MitraClip^®, is a safe and effective procedure for severe mitral valve regurgitation (MR). However, the therapeutic results of MitraClip^® in Qatar remain to be elucidated. A total of 25 patients (mean age 60 ± 14.5 years, 64% males) with symptomatic severe MR and prohibitive surgical risks were enrolled in this study. The procedural success rate was 92% to achieve mild residual MR. There was no periprocedural death. All patients experienced significant improvement in heart failure symptoms and MR grade postprocedure with sustained improvement over 1-year follow-up. Conclusion: The TMVr procedure using the MitraClip^® device was safe and resulted in meaningful and sustained functional status and echocardiographic parameter improvement.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	684

Printed	68

Emailed	0

PDF Downloaded	32

Comments	[Add]